Metabolomics for hematologic malignancies: Advances and perspective

被引:0
|
作者
Li, Xinglan [1 ]
Xu, Mengyu [1 ]
Chen, Yanying [2 ]
Zhai, Yongqing [3 ]
Li, Junhong [1 ]
Zhang, Ning [4 ]
Yin, Jiawei [5 ,6 ,7 ]
Wang, Lijuan [5 ,6 ,7 ,8 ]
机构
[1] Shandong Second Med Univ, Linyi Peoples Hosp, Linyi, Peoples R China
[2] Linyi Peoples Hosp, Hematol Lab, Linyi, Peoples R China
[3] Linyi Peoples Hosp, Dept Orthoped, Linyi, Peoples R China
[4] Linyi Peoples Hosp, Dept Anesthesiol, Linyi, Peoples R China
[5] Linyi Peoples Hosp, Cent Lab, Linyi, Peoples R China
[6] Key Lab Tumor Biol, Linyi, Peoples R China
[7] Xuzhou Med Univ, Key Lab Translat Oncol, Xuzhou, Peoples R China
[8] Linyi Peoples Hosp, Dept Hematol, Linyi, Peoples R China
关键词
amino acid metabolism; glucose metabolism; leukemia; lipid metabolism; lymphoma; myeloma; ACUTE MYELOID-LEUKEMIA; B-CELL LYMPHOMA; METABOLISM; SERUM; MICROENVIRONMENT; CHROMATOGRAPHY; PROLIFERATION; BIOMARKERS; SIGNATURE; RESISTANT;
D O I
10.1097/MD.0000000000039782
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With the use of advanced technology, metabolomics allows for a thorough examination of metabolites and other small molecules found in biological specimens, blood, and tissues. In recent years, metabolomics has been recognized that is closely related to the development of malignancies in the hematological system. Alterations in metabolomic pathways and networks are important in the pathogenesis of hematologic malignancies and can also provide a theoretical basis for early diagnosis, efficacy evaluation, accurate staging, and individualized targeted therapy. In this review, we summarize the progress of metabolomics, including glucose metabolism, amino acid metabolism, and lipid metabolism in lymphoma, myeloma, and leukemia through specific mechanisms and pathways. The research of metabolomics gives a new insight and provides therapeutic targets for the treatment of patients with hematologic malignancies.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Angiogenesis in hematologic malignancies
    Moehler, TM
    Neben, K
    Ho, AD
    Goldschmidt, H
    ANNALS OF HEMATOLOGY, 2001, 80 (12) : 695 - 705
  • [42] Hematologic malignancies of the pancreas
    Kumar Sandrasegaran
    Anderanik Tomasian
    Khaled M. Elsayes
    Harris Nageswaran
    Akram Shaaban
    Alampady Shanbhogue
    Christine O. Menias
    Abdominal Imaging, 2015, 40 : 411 - 423
  • [43] The Microbiota in Hematologic Malignancies
    Song, Yajing
    Himmel, Bryan
    Ohrmalm, Lars
    Gyarmati, Peter
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (01)
  • [44] Hereditary Hematologic Malignancies
    DiNardo, Courtney
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S27 - S29
  • [45] Neoantigens in Hematologic Malignancies
    Biernacki, Melinda A.
    Bleakley, Marie
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [46] Gemcitabine in hematologic malignancies
    Nabhan, C
    Krett, N
    Gandhi, V
    Rosen, S
    CURRENT OPINION IN ONCOLOGY, 2001, 13 (06) : 514 - 521
  • [47] Anemia and hematologic malignancies
    Cahn, Jean-Yves
    HEMATOLOGIE, 2006, 12 : 2 - 2
  • [48] Angiogenesis in hematologic malignancies
    T. Moehler
    K. Neben
    A. Ho
    H. Goldschmidt
    Annals of Hematology, 2001, 80 : 695 - 705
  • [49] Hematologic Malignancies of the Breast
    Alsadi, Alaa
    Murro, Diana
    Martyn, Colin
    Miller, Ira
    Gattuso, Paolo
    MODERN PATHOLOGY, 2015, 28 : 33A - 33A
  • [50] Hematologic malignancies and thrombosis
    Elice, F.
    Rodeghiero, F.
    THROMBOSIS RESEARCH, 2012, 129 (03) : 360 - 366